Conference Call with Torrent Pharmaceuticals Management and Analysts on Q1FY25 Performance and Outlook. Listen to the full earnings transcript.
Pharmaceuticals company Torrent Pharmaceuticals announced Q1FY25 results: Revenue at Rs 2,859 crore grew by 10% Gross Margin: 75.7%, Op. EBITDA margin at 31.6%, Growth: 14% Net Profit after tax at Rs 457 crore, up by 21% Other expenses include one-off expenses of Rs 20 crore (in international business) Adjusted for such one-off expenses, the underlying Op. EBITDA is Rs 924 crore and Op. EBITDA margin at 32.3% Result PDF